These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20418070)

  • 21. Differential aqueous and vitreous concentrations of moxifloxacin and ofloxacin after topical administration one hour before vitrectomy.
    Lai WW; Chu KO; Chan KP; Choy KW; Wang CC; Tsang CW; Pang CP
    Am J Ophthalmol; 2007 Aug; 144(2):315-8. PubMed ID: 17659971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.
    Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Patanella S; Siccardi M; Sciandra M; Di Perri G
    Ther Drug Monit; 2009 Feb; 31(1):104-9. PubMed ID: 19077929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics after intravenous, intramuscular and subcutaneous administration of moxifloxacin in sheep.
    Cárceles CM; Escudero E; Fernández-Varón E; Marín P
    Vet J; 2009 Jun; 180(3):343-7. PubMed ID: 18406644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penetration of moxifloxacin into bone in patients undergoing total knee arthroplasty.
    Malincarne L; Ghebregzabher M; Moretti MV; Egidi AM; Canovari B; Tavolieri G; Francisci D; Cerulli G; Baldelli F
    J Antimicrob Chemother; 2006 May; 57(5):950-4. PubMed ID: 16551691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of intravenously administered moxifloxacin in eye compartments: an experimental study.
    Tzepi I; Vergados I; Kanellakopoulou K; Papathanassiou M; Kranidioti H; Tsaganos T; Liarakos V; Giamarellos-Bourboulis EJ; Theodossiadis P
    Int J Antimicrob Agents; 2009 Feb; 33(2):160-2. PubMed ID: 18947985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H; Rink AD; Delesen H; Kubitza D; Vestweber KH
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and bioavailability of moxifloxacin in buffalo calves.
    Pathania R; Sharma SK
    Res Vet Sci; 2010 Aug; 89(1):108-12. PubMed ID: 20202656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moxifloxacin penetration into human gastrointestinal tissues.
    Wirtz M; Kleeff J; Swoboda S; Halaceli I; Geiss HK; Hoppe-Tichy T; Büchler MW; Friess H
    J Antimicrob Chemother; 2004 May; 53(5):875-7. PubMed ID: 15056642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic-pharmacodynamic integration of moxifloxacin in rabbits after intravenous, intramuscular and oral administration.
    Fernández-Varón E; Bovaira MJ; Espuny A; Escudero E; Vancraeynest D; Cárceles CM
    J Vet Pharmacol Ther; 2005 Aug; 28(4):343-8. PubMed ID: 16050813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of newer quinolones in the empyema fluid.
    Liapakis IE; Kottakis I; Tzatzarakis MN; Tsatsakis AM; Pitiakoudis MS; Ypsilantis P; Light RW; Simopoulos CE; Bouros DE
    Eur Respir J; 2004 Sep; 24(3):466-70. PubMed ID: 15358708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of fluoroquinolones in critical care patients: A bio-analytical HPLC method for the simultaneous quantification of ofloxacin, ciprofloxacin and moxifloxacin in human plasma.
    De Smet J; Boussery K; Colpaert K; De Sutter P; De Paepe P; Decruyenaere J; Van Bocxlaer J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Apr; 877(10):961-7. PubMed ID: 19272845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrations of moxifloxacin in plasma and urine, and penetration into prostatic fluid and ejaculate, following single oral administration of 400 mg to healthy volunteers.
    Wagenlehner FM; Kees F; Weidner W; Wagenlehner C; Naber KG
    Int J Antimicrob Agents; 2008 Jan; 31(1):21-6. PubMed ID: 18054465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
    Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
    Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, plasma protein binding and bioavailability of moxifloxacin in Muscovy ducks after different routes of administration.
    Goudah A; Hasabelnaby S
    Res Vet Sci; 2010 Jun; 88(3):507-11. PubMed ID: 20004428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-performance liquid chromatography assay for moxifloxacin: pharmacokinetics in human plasma.
    Tatar Ulu S
    J Pharm Biomed Anal; 2007 Jan; 43(1):320-4. PubMed ID: 16872782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplacental passage of insulin in pregnant women with insulin-dependent diabetes mellitus. Its role in fetal macrosomia.
    Menon RK; Cohen RM; Sperling MA; Cutfield WS; Mimouni F; Khoury JC
    N Engl J Med; 1990 Aug; 323(5):309-15. PubMed ID: 2195347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
    Ober MC; Hoppe-Tichy T; Köninger J; Schunter O; Sonntag HG; Weigand MA; Encke J; Gutt C; Swoboda S
    J Antimicrob Chemother; 2009 Nov; 64(5):1091-5. PubMed ID: 19734170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal timing of ampicillin administration to pregnant women for establishing bactericidal levels in the prophylaxis of Group B Streptococcus.
    Colombo DF; Lew JL; Pedersen CA; Johnson JR; Fan-Havard P
    Am J Obstet Gynecol; 2006 Feb; 194(2):466-70. PubMed ID: 16458647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
    Deryke CA; Du X; Nicolau DP
    J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.